Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 15, 2017 Filed Dec 19, 2017 15:01 UTC |
FULGONI GIANDirector
|
SaleCommon Stock | 20,000 | $44.38 | $887,600.00 |
DisclosureSEC source: 0001437749-17-020884 · rdgdoc.xml · nonDerivative · entry 1 FULGONI GIAN · CIK 0001254384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,900 Read SEC document |
| October 27, 2017 Filed Oct 31, 2017 13:55 UTC |
KORN RONALD JDirector
|
SaleCommon Stock | 1,000 | $35.57 | $35,570.00 |
DisclosureSEC source: 0001437749-17-017900 · rdgdoc.xml · nonDerivative · entry 1 KORN RONALD J · CIK 0001249320 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,833 Read SEC document |
| August 01, 2017 Filed Aug 2, 2017 19:32 UTC |
SCHWEITZER ROBERT CDirector
|
SaleCommon Stock | 2,500 | $49.18 | $122,950.00 |
DisclosureSEC source: 0001437749-17-013570 · rdgdoc.xml · nonDerivative · entry 1 SCHWEITZER ROBERT C · CIK 0001254385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,834 Read SEC document |
| August 01, 2017 Filed Aug 7, 2017 15:28 UTC Amendment |
SCHWEITZER ROBERT CDirector
|
SaleCommon Stock | 2,500 | $49.18 | $122,950.00 |
DisclosureSEC source: 0001437749-17-013918 · rdgdoc.xml · nonDerivative · entry 1 SCHWEITZER ROBERT C · CIK 0001254385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,334 Read SEC document |
| July 28, 2017 Filed Jul 31, 2017 14:47 UTC |
FORMICA FRANK JDirector
|
GrantCommon Stock | 7,500 | $48.37 | $362,775.00 |
DisclosureSEC source: 0001437749-17-013341 · rdgdoc.xml · nonDerivative · entry 1 FORMICA FRANK J · CIK 0001263825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,500 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three year period condition upon continued employment. Mr. Formica retains voting rights over all the shares while in escrow. Read SEC document |
| July 28, 2017 Filed Jul 31, 2017 14:47 UTC |
FULGONI GIANDirector
|
GrantCommon Stock | 7,500 | $48.37 | $362,775.00 |
DisclosureSEC source: 0001437749-17-013340 · rdgdoc.xml · nonDerivative · entry 1 FULGONI GIAN · CIK 0001254384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,900 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three year period condition upon continued employment. Mr. Fulgoni retains voting rights over all the shares while in escrow. Read SEC document |
| July 28, 2017 Filed Jul 31, 2017 14:46 UTC |
KORN RONALD JDirector
|
GrantCommon Stock | 7,500 | $48.37 | $362,775.00 |
DisclosureSEC source: 0001437749-17-013339 · rdgdoc.xml · nonDerivative · entry 2 KORN RONALD J · CIK 0001249320 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,833 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three year period condition upon continued employment. Mr. Korn retains voting rights over all the shares while in escrow. Read SEC document |
| July 28, 2017 Filed Jul 31, 2017 14:46 UTC |
KORN RONALD JDirector
|
SaleCommon Stock | 5,000 | $48.18 | $240,900.00 |
DisclosureSEC source: 0001437749-17-013339 · rdgdoc.xml · nonDerivative · entry 1 KORN RONALD J · CIK 0001249320 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,333 Read SEC document |
| July 28, 2017 Filed Jul 31, 2017 14:46 UTC |
SCHWEITZER ROBERT CDirector
|
GrantCommon Stock | 7,500 | $48.37 | $362,775.00 |
DisclosureSEC source: 0001437749-17-013338 · rdgdoc.xml · nonDerivative · entry 2 SCHWEITZER ROBERT C · CIK 0001254385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,334 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three year period condition upon continued employment. Mr. Schweitzer retains voting rights over all the shares while in escrow. Read SEC document |
| July 28, 2017 Filed Jul 31, 2017 14:45 UTC |
ROSENBLOOM BRUCE SChief Financial Officer
|
GrantCommon Stock | 10,500 | $48.37 | $507,885.00 |
DisclosureSEC source: 0001437749-17-013337 · rdgdoc.xml · nonDerivative · entry 2 ROSENBLOOM BRUCE S · CIK 0001251340 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,934 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2016 Employee Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three year period condition upon continued employment. Mr. Rosenbloom retains voting rights over all the shares while in escrow. Read SEC document |
| July 27, 2017 Filed Jul 31, 2017 14:46 UTC |
SCHWEITZER ROBERT CDirector
|
SaleCommon Stock | 5,000 | $48.60 | $243,000.00 |
DisclosureSEC source: 0001437749-17-013338 · rdgdoc.xml · nonDerivative · entry 1 SCHWEITZER ROBERT C · CIK 0001254385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,834 Read SEC document |
| July 27, 2017 Filed Jul 31, 2017 14:45 UTC |
ROSENBLOOM BRUCE SChief Financial Officer
|
SaleCommon Stock | 6,833 | $50.18 | $342,879.94 |
DisclosureSEC source: 0001437749-17-013337 · rdgdoc.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,534 Read SEC document |
| May 16, 2017 Filed May 16, 2017 21:18 UTC |
FORMICA FRANK JDirector
|
SaleCommon Stock | 5,000 | $35.32 | $176,600.00 |
DisclosureSEC source: 0001553350-17-000621 · formica4.xml · nonDerivative · entry 1 FORMICA FRANK J · CIK 0001263825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,000 Read SEC document |
| May 10, 2017 Filed May 11, 2017 17:05 UTC |
KORN RONALD JDirector
|
SaleCommon Stock | 3,000 | $31.84 | $95,520.00 |
DisclosureSEC source: 0001553350-17-000545 · korn4.xml · nonDerivative · entry 1 KORN RONALD J · CIK 0001249320 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,333 Read SEC document |
| May 10, 2017 Filed May 11, 2017 17:03 UTC |
FULGONI GIANDirector
|
SaleCommon Stock | 35,000 | $32.22 | $1,127,700.00 |
DisclosureSEC source: 0001553350-17-000544 · fulgoni4.xml · nonDerivative · entry 1 FULGONI GIAN · CIK 0001254384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,400 Read SEC document |
| May 10, 2017 Filed Jul 14, 2017 15:55 UTC Amendment |
FULGONI GIANDirector
|
SaleCommon Stock | 35,000 | $32.22 | $1,127,700.00 |
DisclosureSEC source: 0001553350-17-000832 · fulgoni4.xml · nonDerivative · entry 1 FULGONI GIAN · CIK 0001254384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,400 Read SEC document |
| May 08, 2017 Filed May 9, 2017 19:53 UTC |
ROSENBLOOM BRUCE SCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 9,000 | $27.00 | $243,000.00 |
DisclosureSEC source: 0001553350-17-000512 · rosenbloom4.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,267 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| May 01, 2017 Filed May 3, 2017 17:41 UTC |
ROSENBLOOM BRUCE SCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 1,500 | $24.00 | $36,000.00 |
DisclosureSEC source: 0001553350-17-000479 · rosenbloom4.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,267 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| December 13, 2016 Filed Dec 14, 2016 20:54 UTC |
AKDAG MENDERESDirector · CEO & President
|
SaleCommon Stock | 10,000 | $23.00 | $230,000.00 |
DisclosureSEC source: 0001553350-16-002804 · akdag4.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 520,000 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| December 09, 2016 Filed Dec 12, 2016 20:49 UTC |
ROSENBLOOM BRUCE SCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 1,500 | $23.00 | $34,500.00 |
DisclosureSEC source: 0001553350-16-002788 · rosenbloom4.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,767 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| December 07, 2016 Filed Dec 7, 2016 21:10 UTC |
AKDAG MENDERESDirector · CEO & President
|
SaleCommon Stock | 2,674 | $22.75 | $60,833.50 |
DisclosureSEC source: 0001553350-16-002777 · akdag4.xml · nonDerivative · entry 2 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 530,000 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| December 06, 2016 Filed Dec 7, 2016 21:10 UTC |
AKDAG MENDERESDirector · CEO & President
|
SaleCommon Stock | 433 | $22.75 | $9,850.75 |
DisclosureSEC source: 0001553350-16-002777 · akdag4.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 532,674 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| December 01, 2016 Filed Dec 5, 2016 18:28 UTC |
AKDAG MENDERESDirector · CEO & President
|
SaleCommon Stock | 16,893 | $22.60 | $381,781.80 |
DisclosureSEC source: 0001553350-16-002769 · akdag4.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 533,107 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| December 01, 2016 Filed Dec 5, 2016 17:36 UTC |
ROSENBLOOM BRUCE SCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 1,500 | $22.50 | $33,750.00 |
DisclosureSEC source: 0001553350-16-002768 · rosenbloom4.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,267 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| November 25, 2016 Filed Nov 29, 2016 19:05 UTC |
AKDAG MENDERESDirector · CEO & President
|
SaleCommon Stock | 6,274 | $22.25 | $139,596.50 |
DisclosureSEC source: 0001553350-16-002744 · akdag4.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550,000 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| November 21, 2016 Filed Nov 23, 2016 20:01 UTC |
AKDAG MENDERESDirector · CEO & President
|
SaleCommon Stock | 3,726 | $22.25 | $82,903.50 |
DisclosureSEC source: 0001553350-16-002732 · akdag4.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 556,274 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| November 16, 2016 Filed Nov 18, 2016 17:49 UTC |
FORMICA FRANK JDirector
|
SaleCommon Stock | 10,000 | $21.75 | $217,500.00 |
DisclosureSEC source: 0001553350-16-002701 · formica4.xml · nonDerivative · entry 1 FORMICA FRANK J · CIK 0001263825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,000 Read SEC document |
| November 14, 2016 Filed Nov 15, 2016 19:24 UTC |
AKDAG MENDERESDirector · CEO & President
|
SaleCommon Stock | 30,000 | $21.75 | $652,500.00 |
DisclosureSEC source: 0001553350-16-002682 · akdag4.xml · nonDerivative · entry 2 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 560,000 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| November 14, 2016 Filed Nov 15, 2016 19:25 UTC |
ROSENBLOOM BRUCE SCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 3,000 | $21.75 | $65,250.00 |
DisclosureSEC source: 0001553350-16-002683 · rosenbloom4.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,767 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| November 11, 2016 Filed Nov 15, 2016 19:24 UTC |
AKDAG MENDERESDirector · CEO & President
|
SaleCommon Stock | 10,000 | $21.25 | $212,500.00 |
DisclosureSEC source: 0001553350-16-002682 · akdag4.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 590,000 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| October 10, 2016 Filed Oct 11, 2016 16:40 UTC |
ROSENBLOOM BRUCE SCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 1,500 | $21.00 | $31,500.00 |
DisclosureSEC source: 0001553350-16-002521 · rosenbloom4.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,767 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| October 10, 2016 Filed Oct 11, 2016 16:39 UTC |
AKDAG MENDERESDirector · CEO & President
|
SaleCommon Stock | 10,000 | $21.00 | $210,000.00 |
DisclosureSEC source: 0001553350-16-002520 · akdag4.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,000 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| September 22, 2016 Filed Sep 26, 2016 19:50 UTC |
AKDAG MENDERESDirector · CEO & President
|
SaleCommon Stock | 10,000 | $20.75 | $207,500.00 |
DisclosureSEC source: 0001553350-16-002495 · akdag4.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 610,000 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| July 29, 2016 Filed Sep 12, 2016 21:44 UTC Amendment |
FULGONI GIANDirector
|
GrantCommon Stock | 7,500 | $20.73 | $155,475.00 |
DisclosureSEC source: 0001553350-16-002462 · fulgoni4.xml · nonDerivative · entry 1 FULGONI GIAN · CIK 0001254384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,400 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three year period condition upon continued employment. Mr. Fulgoni retains voting rights over all the shares while in escrow. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.